Back to Search Start Over

Study Shows Clinical Utility of the Prospera Test in Nephrology Practice

Source :
Plus Company Updates. September 2, 2020
Publication Year :
2020

Abstract

SAN CARLOS: Natera, Inc. has issued the following news release: Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a prospective, [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.634286805